Genomic Biomarker Market Outlook 2025: Detailed Trends, Size & Share Analysis

24 Apr, 2025

The Genomic Biomarker Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.

What are the Historical Growth Trends in the Genomic Biomarker Market?

The market size of the genomic biomarker has experienced swift growth in recent years. It is expected to expand from $8.4 billion in 2024 to $9.9 billion in 2025, with a compound annual growth rate (CAGR) of 18.0%.

What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Genomic Biomarker Industry?

The Genomic Biomarker global market is projected to reach a value of $18.93 billion in 2029, with a compound annual growth rate (CAGR) of 17.6%.

Download Your Free Sample of the 2025 Genomic Biomarker Market Report and Uncover Key Trends Now!

What are the Key Growth Drivers Fueling the Genomic Biomarker Market?

The key drivers in the genomic biomarker market are:

• Growing focus on the availability of personalized medications
• Rising occurrences of cardiovascular and neurological diseases
• Increasing investments in genomic research
• Growing adoption of personalized nutrition

Global Market Segmentation: Identifying Major Genomic Biomarker Industry Segments

The genomic biomarker market covered in this report is segmented –
1) By Type: Predictive Biomarkers, Prognostic Biomarkers
2) By Disease Indication: Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Other Disease Indications
3) By Validation: Analytical Validation, Clinical Validation, Clinical Utility
4) By End-User: Hospitals, Diagnostic Centers, Research Laboratories, Other End Users Subsegments:
1) By Predictive Biomarkers: Genetic Biomarkers For Disease Susceptibility, Pharmacogenomic Biomarkers For Drug Response, Early Detection Biomarkers For Disease Prediction, Biomarkers For Treatment Response Prediction
2) By Prognostic Biomarkers: Biomarkers For Disease Progression, Biomarkers For Outcome Prediction, Survival And Recurrence Biomarkers, Biomarkers For Treatment Efficacy And Prognosis

Pre-order the 2025 Genomic Biomarker Global Market Report for Fast Delivery & Comprehensive Insights!

What are the emerging Trends Shaping the Future of the Genomic Biomarker Market?

The key trends in the genomic biomarker market are:

• Technological advancements are shaping the future of the genomic biomarker market.
• The incorporation of digital health tools is an emerging trend.
• The application of artificial intelligence and machine learning in genomic biomarkers is becoming more prevalent.
• The trend of personalized medicine continues to influence the genomic biomarker market.

Who Are the Top Competitors & Leading Players in the Genomic Biomarker Market?

Major players in the genomic biomarker market are:

• Pfizer Inc.
• Roche Diagnostics
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Eurofins Scientific SE
• Agilent Technologies Inc.
• Illumina Inc.
• PerkinElmer Inc.
• Beckman Coulter Inc.
• Bio-Rad Laboratories Inc.
• Foundation Medicine Inc.
• QIAGEN N.V.
• Almac Group Ltd.
• Myriad Genetics Inc.
• Invitae Inc.
• Guardant Health Inc.
• Novogene Inc.
• Twist Bioscience Corp.
• NanoString Technologies Inc.
• Quanterix Corp.
• Personalis Inc.
• GENEWIZ Inc.
• Agena Bioscience Inc.
• Creative Diagnostics Ltd.
• OncoDNA SA
• Genome Life Sciences Ltd.
• Epigenomics AG.

Regional Dominance: Which Area Leads the Global Template Market?

North America was the largest region in the genomic biomarker market in 2024